SmSP2: an anti-hemostatic serine protease secreted by the blood fluke pathogen, Schistosoma mansoni

Adrian Leontovyc1,2, Lenka Ulrychova1, Anthony J. O’Donoghue3, Lucie Maresova1, Pavla Fajtova1,2, Jiri Vondrasek1, Conor R. Caffrey3, Michael Mares1, Martin Horn1, Jan Dvorak1

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam. 2, Prague, Czech Republic, fajtova@uochb.cas.cz

First Faculty of Medicine, Charles University in Prague, Katerinska 1660/32, Prague, Czech Republic

Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Drive, University of California San Diego, California, USA

 

Schistosomiasis caused by parasitic blood flukes of the genus Schistosoma is the second most important parasitic infection after malaria with more than 240 million people infected. There is an urgent need to identify novel anti-schistosomal targets for therapeutic interventions. Our work is focused on S. mansoni serine protease 2 (SmSP2). It was localized in the tegument and esophageal glands, ovaries, testes and vitelaria of adult schistosomes by immunofluorescence microscopy and in situ RNA hybridization. Enzyme activity measurements and immunoblotting identified SmSP2 in the excretory/secretory products. Recombinant SmSP2 was produced in the Pichia pastoris expression system and its cleavage specificity was investigated using combinatorial substrate libraries and 3D model analysis. SmSP2 was found to activate plasmin, the key component of the fibrinolytic system, and releases vasoregulatory kinins from kininogen. Our results suggest that SmSP2 plays a role in host-parasite interactions and represents a potential target for novel drug or vaccine interventions.